With respect to E-cadherin status, of the 79 E-cadherin-positive carcinomas, 46 tumours (58.3%) were hypervascular; of the 71 E-cadherin-negative carcinomas, 36 tumours (50.7%) were hypervascular. This evidence concerns the gene CDH1 and neoplasm.